X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5878) 5878
Book Review (938) 938
Publication (308) 308
Book Chapter (47) 47
Conference Proceeding (29) 29
Newsletter (19) 19
Magazine Article (7) 7
Book / eBook (6) 6
Web Resource (6) 6
Dissertation (3) 3
Government Document (3) 3
Newspaper Article (3) 3
Trade Publication Article (2) 2
Reference (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (4638) 4638
humans (4606) 4606
philadelphia chromosome (3541) 3541
hematology (2203) 2203
philadelphia-chromosome (2101) 2101
oncology (2046) 2046
chronic myelogenous leukemia (2021) 2021
male (1994) 1994
female (1837) 1837
adult (1663) 1663
middle aged (1547) 1547
leukemia, myelogenous, chronic, bcr-abl positive - genetics (1498) 1498
chronic myeloid-leukemia (1423) 1423
imatinib mesylate (1040) 1040
fusion proteins, bcr-abl - genetics (1036) 1036
aged (959) 959
chronic myeloid leukemia (955) 955
bcr-abl (877) 877
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (874) 874
leukemia (866) 866
leukemia, myelogenous, chronic, bcr-abl positive - pathology (819) 819
benzamides (791) 791
imatinib (706) 706
adolescent (702) 702
precursor cell lymphoblastic leukemia-lymphoma - genetics (672) 672
acute lymphoblastic-leukemia (669) 669
animals (646) 646
prognosis (614) 614
antineoplastic agents - therapeutic use (602) 602
abridged index medicus (601) 601
karyotyping (601) 601
cancer (596) 596
translocation, genetic (591) 591
pyrimidines - therapeutic use (571) 571
cml (518) 518
piperazines - therapeutic use (518) 518
mice (497) 497
treatment outcome (486) 486
child (461) 461
blast crisis (433) 433
genetic aspects (425) 425
hemic and lymphatic diseases (410) 410
genetics & heredity (393) 393
mutation (391) 391
therapy (386) 386
chemotherapy (385) 385
acute lymphoblastic leukemia (384) 384
leukemia, myelogenous, chronic, bcr-abl positive - therapy (383) 383
protein kinase inhibitors - therapeutic use (378) 378
tyrosine kinase (364) 364
research (359) 359
chromosome aberrations (347) 347
in situ hybridization, fluorescence (346) 346
leukemia, myeloid - genetics (344) 344
remission induction (343) 343
precursor cell lymphoblastic leukemia-lymphoma - drug therapy (340) 340
fusion proteins, bcr-abl - metabolism (339) 339
transplantation (339) 339
cell biology (330) 330
polymerase chain reaction (325) 325
antineoplastic combined chemotherapy protocols - therapeutic use (315) 315
dasatinib (314) 314
care and treatment (310) 310
precursor cell lymphoblastic leukemia-lymphoma - therapy (309) 309
minimal residual disease (308) 308
biochemistry & molecular biology (306) 306
pyrimidines - pharmacology (303) 303
tyrosine kinase inhibitor (303) 303
young adult (300) 300
gene (296) 296
abl tyrosine kinase (294) 294
bone marrow transplantation (283) 283
chronic myelocytic-leukemia (283) 283
base sequence (281) 281
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis (281) 281
protein-tyrosine kinases - antagonists & inhibitors (275) 275
molecular sequence data (274) 274
child, preschool (269) 269
stem cells (269) 269
aged, 80 and over (268) 268
tumor cells, cultured (267) 267
bone marrow - pathology (266) 266
analysis (264) 264
cells (255) 255
piperazines - pharmacology (255) 255
precursor cell lymphoblastic leukemia-lymphoma - pathology (252) 252
tyrosine (251) 251
leukemia, myelogenous, chronic, bcr-abl positive - metabolism (249) 249
apoptosis (246) 246
hematopoietic stem cell transplantation (246) 246
antineoplastic agents - pharmacology (241) 241
cytogenetics (238) 238
chromosomes (236) 236
tyrosine kinase inhibitors (236) 236
acute lymphocytic leukemia (235) 235
translocation (232) 232
bone marrow (229) 229
bcr (228) 228
hematology, oncology and palliative medicine (228) 228
interferon-alpha (228) 228
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5477) 5477
Japanese (119) 119
Chinese (76) 76
Spanish (72) 72
French (66) 66
German (41) 41
Russian (34) 34
Polish (16) 16
Hungarian (15) 15
Portuguese (10) 10
Czech (8) 8
Korean (8) 8
Italian (7) 7
Ukrainian (5) 5
Danish (3) 3
Serbian (3) 3
Hebrew (2) 2
Romanian (2) 2
Croatian (1) 1
Finnish (1) 1
Norwegian (1) 1
Slovak (1) 1
Slovenian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2013, ISBN 1615190678, xiii, 303 p., [8] p. of plates
Book
The New England Journal of Medicine, ISSN 0028-4793, 11/2012, Volume 367, Issue 22, pp. 2075 - 2088
Ponatinib was developed to overcome resistance to the tyrosine kinase inhibitors used to treat leukemias that are positive for the Philadelphia chromosome. In... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, GENERAL & INTERNAL | RESPONSE CRITERIA | KINASE DOMAIN MUTATIONS | DIAGNOSED CHRONIC-PHASE | TYROSINE KINASE | INTERNATIONAL-WORKING-GROUP | FOLLOW-UP | CLINICAL RESISTANCE | BCR-ABL INHIBITOR | CHRONIC MYELOID-LEUKEMIA | Amylases - blood | Lipase - blood | Follow-Up Studies | Humans | Middle Aged | Imidazoles - chemistry | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Imidazoles - administration & dosage | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - genetics | Drug Resistance, Neoplasm | Male | Structure-Activity Relationship | Antineoplastic Agents - administration & dosage | Dose-Response Relationship, Drug | Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy | Protein-Tyrosine Kinases - genetics | Antineoplastic Agents - adverse effects | Pyridazines - administration & dosage | Aged, 80 and over | Adult | Female | Pyridazines - adverse effects | Imidazoles - adverse effects | Antineoplastic Agents - chemistry | Pancreatitis - chemically induced | Pyridazines - chemistry | Fusion Proteins, bcr-abl - genetics | Fusion Proteins, bcr-abl - antagonists & inhibitors | Aged | Mutation | Protein-Tyrosine Kinases - antagonists & inhibitors | Patient outcomes | BCR-ABL tyrosine kinase inhibitors | Dosage and administration | Genetic aspects | Acute lymphocytic leukemia | Research | Drug therapy | Tyrosine | BCR protein | Acute lymphatic leukemia | Myeloid leukemia | Leukemia | Pancreatitis | Abl protein | Chronic myeloid leukemia | Lymphatic leukemia | Lipase | Kinases | Philadelphia chromosome | Proteins | Myelosuppression | Fusion protein | Protein-tyrosine kinase | Binding sites | Index Medicus | Abridged Index Medicus
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 19, pp. 1783 - 1796
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 31, pp. 5175 - 5181
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2010, Volume 28, Issue 24, pp. 3880 - 3889
Journal Article
Journal Article
Cancer, ISSN 0008-543X, 05/2007, Volume 109, Issue 10, pp. 2068 - 2076
Journal Article
Blood, ISSN 0006-4971, 08/2016, Volume 128, Issue 6, pp. 774 - 782
Journal Article
Cancer, ISSN 0008-543X, 04/2011, Volume 117, Issue 8, pp. 1583 - 1594
The Philadelphia chromosome (Ph) is the most common cytogenetic abnormality associated with adult acute lymphoblastic leukemia (ALL). Before the advent of... 
tyrosine kinase inhibitors | imatinib resistance | acute lymphoblastic leukemia | Philadelphia chromosome
Journal Article